Test Bench for Right Ventricular Failure Reversibility: The Hybrid BiVAD Concept
Open Access
- 10 December 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (24) , 7604
Abstract
Background: When heart transplantation and myocardial recovery are unlikely, patients presenting with biventricular cardiogenic shock initially treated with extracorporeal membrane oxygenation (ECMO) may benefit from a mechanical support upgrade. In this scenario, a micro-invasive approach is proposed: the combination of the double-lumen ProtekDuo cannula (Livanova, London, UK) and the Impella 5.5 (Abiomed, Danvers, MA) trans-aortic pump that translates into a hybrid BiVAD. Methods: All consecutive ECMO patients presenting with biventricular cardiogenic shock and ineligibility to heart transplantation from August 2022 were prospectively enrolled. The clinical course, procedural details, and in-hospital events were collected via electronic medical records. Results: A total of three patients, who were temporarily not eligible for heart transplantation or durable LVAD due to severe acute pneumonia and right ventricular (RV) dysfunction, were implanted with a hybrid BiVAD. This strategy provided high-flow biventricular support while pulmonary function ameliorated. Moreover, by differentially sustaining the systemic and pulmonary circulation, it allowed for a more adequate reassessment of RV function. All the patients were considered eligible for isolated durable LVAD and underwent less invasive LVAD implantation paired with a planned postoperative RVAD. In all cases, RV function gradually recovered and the RVAD was successfully removed. Conclusions: The Hybrid BiVAD represents an up-to-date micro-invasive mechanical treatment of acute biventricular failure beyond ECMO. Its rationale relies on more physiological circulation across the lungs, the complete biventricular unloading, and the possibility of including an oxygenator in the circuit. Finally, the independent and differential control of pulmonary and systemic flows allows for more accurate RV function evaluation for isolated durable LVAD eligibility reassessment.Keywords
This publication has 55 references indexed in Scilit:
- Acute Mechanical Circulatory Support for Fulminant Myocarditis Complicated by Cardiogenic ShockJournal of Cardiovascular Translational Research, 2014
- CentriMag(R) short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 daysEuropean Journal of Cardio-Thoracic Surgery, 2013
- Less Invasive Surgical and Perfusion Technique for Implantation of the Jarvik 2000 Left Ventricular Assist DeviceThe Annals of Thoracic Surgery, 2013
- Percutaneous biventricular cardiac assist device in cardiogenic shockEuropean Heart Journal, 2013
- Levitronix CentriMag Third-Generation Magnetically Levitated Continuous Flow Pump as Bridge to SolutionASAIO Journal, 2011
- Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory supportThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Bridging patients after salvage from bridge to decision directly to transplant by means of prolonged support with the CentriMag short-term centrifugal pumpThe Journal of Thoracic and Cardiovascular Surgery, 2009
- The Papworth Experience With the Levitronix CentriMag Ventricular Assist DeviceThe Journal of Heart and Lung Transplantation, 2008
- Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failureThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Levitronix as a Short-term Salvage Treatment for Primary Graft Failure After Heart TransplantationThe Journal of Heart and Lung Transplantation, 2006